We have shown that IL-1β inhibition stably reduces tumor growth, by limiting inflammation and by inducing the maturation of MDSCs into M1 macrophages, which do not promote tumor invasiveness and can be cytotoxic/cytostatic for tumor cells and can also serve as APCs that induce anti-tumor immunity. The gene discussed is IL1B; the disease is neoplasm.